Ascorbic acid 500mg tablets

País: Regne Unit

Idioma: anglès

Font: MHRA (Medicines & Healthcare Products Regulatory Agency)

ingredients actius:

Ascorbic acid

Disponible des:

Alissa Healthcare Research Ltd

Codi ATC:

A11GA01

Designació comuna internacional (DCI):

Ascorbic acid

Dosis:

500mg

formulario farmacéutico:

Oral tablet

clase:

No Controlled Drug Status

tipo de receta:

Valid as a prescribable product

Resumen del producto:

BNF: 09060301

Informació per a l'usuari

Patient Information Lea
f
l
e
t A
S
C
O
R
B
I
C
A
C
I
D 50
0
M
G
T
AB
L
E
T
S
This medicine will be called Ascorbic Acid
T
a
b
l
e
t
s
in this
l
ea
f
l
e
t
.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE.
• Keep this leaflet. You may need to read it again.
• This medicine is only for you. Do not give it to
anyone else to take. It may harm them, even if
their symptoms are the same as yours.
• If you have any further questions, please ask your
doctor or pharmacist.
• If you get any side effects talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
IN
THIS
L
E
A
FL
E
T
:
1. What Ascorbic Acid Tablets are and what they a
r
e
used
f
o
r
2. Before you take Ascorbic Acid
T
a
b
l
e
t
s
3. How to take Ascorbic Acid
T
a
b
l
e
t
s
4. Possible side e
ff
e
c
t
s
5. How to store Ascorbic Acid
T
a
b
l
e
t
s
6. Further
i
n
f
o
rm
a
t
io
n
1. WHAT ASCORBIC ACID
TABLETS
ARE
A
ND
WHAT THEY ARE USED
F
O
R
These tablets contain the active ingredient, a
s
c
o
r
b
i
c
acid. Ascorbic acid is the chemical name for
V
i
t
a
m
i
n
C. The tablets can be used to increase the amount
o
f
Vitamin C in the
d
i
e
t
.
Vitamin C Tablets are used to treat Vitamin C
deficiency including the prevention and treatment of
scurvy.
2. BEFORE YOU TAKE ASCORBIC ACID
TA
B
LE
T
S
SOME
PEOPLE
MUST NOT
TAKE THESE
T
A
B
L
E
T
S.
DO
NOT TAKE THESE TABLETS
IF
:
•
You know you are allergic to ascorbic acid or to any
of the other ingredients
(
t
h
e
s
e are listed in Section 6
)
•
You suffer from hyperoxaluria
(
e
x
c
e
ss
oxalic acid
i
n
the
ur
i
n
e
)
.
YOU
MUST
BE
ESPECIALLY CAREFUL
IF
:
•
You are pregnant or
b
r
ea
s
t
f
ee
d
i
n
g
.
•
You have an intolerance to some sugars.
T
h
e
s
e
tablets contain lactose and
su
c
r
o
s
e.
If any of the conditions above apply to you,
p
l
ea
s
e
discuss your treatment with your doctor before
t
a
ki
n
g
this
m
e
d
i
c
i
n
e.
TAKING OTHER
M
E
DICINES
Ascorbic Acid Tablets can affect some
o
t
h
e
r
medicines you may be taking.

Fitxa tècnica

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ascorbic Acid 500mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 500mg ascorbic acid
Excipients with known effect: contains 3.00 mg/tablet lactose
monohydrate
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
White to off-white uncoated tablets.
Ascorbic Acid 500mg Tablets are 12.5 mm, white to off-white, plain
round, biconvex tablets.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Vitamin C deficiency
Treatment of scurvy
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults: _
_ _
_ _
Therapeutic use – at least 250mg daily in divided doses.
Maximum of 1000mg daily.
_Elderly: _As for other adults. As the dietary intake of vitamin C may
be less in the elderly, they have greater risk
of presenting with vitamin C deficiency.
Method of administration
For oral administration.
4.3
CONTRAINDICATIONS
Ascorbic acid should not be given to patients with hyperoxaluria.
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Increased intake of ascorbic acid over a prolonged period may result
in increased renal clearance of ascorbic
acid, and deficiency may result if the intake is reduced or withdrawn
rapidly. (See section 4.8)
INTERFERENCE WITH SEROLOGICAL TESTING
Ascorbic acid may interfere with tests and assays for urinary glucose,
giving false-negative results with methods
utilising glucose oxidase with indicator (e.g. Labstix, Testape) and
false- positive results with neocuproin
methods.
Estimation of uric acid by phosphotungstate or uricase with copper
reduction and measurement of creatinine in
non-deproteinised serum may also be affected.
High doses of ascorbic acid may give false-negative readings in faecal
occult blood tests.
This product contains lactose. Patients with rare hereditary problems
of galactose intolerance, the Lapp lactase
deficiency or glucose-galactose malabsorption should not take this
medicine.